Researchers identify biomarkers for CAR T-cell therapy neurotoxicity – Healio
|
Researchers identify biomarkers for CAR T-cell therapy neurotoxicity
Healio Serum biomarkers and early fever formed the basis of an algorithm that identified patients at increased risk for cytokine release syndrome and neurotoxicity following treatment with CD19 chimeric antigen receptor T–cell therapy, according to data … |
